Modaresi Esfeh Jamak, Culver Daniel, Plesec Thomas, John Binu
Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA.
Expert Rev Gastroenterol Hepatol. 2015 Mar;9(3):349-58. doi: 10.1586/17474124.2015.958468. Epub 2014 Dec 4.
The liver is one of the most commonly involved extrapulmonary sites in sarcoidosis. Hepatic sarcoidosis has a broad range of presentations from scattered, asymptomatic noncaseating granulomas with normal liver enzymes, which are very common in patients with known pulmonary sarcoidosis, to portal hypertension and cirrhosis, which are relatively uncommon. Diagnosis is based on a combination of clinical, laboratory and histological manifestations. The authors' protocol for management of patients with suspected sarcoidosis of the liver without focal lesions includes a transjugular liver biopsy with portal pressure measurements to confirm the diagnosis, rule out coexisting liver diseases and to identify select patients with fibrosis or portal hypertension for consideration of immunosuppression. Steroids and azathioprine are the preferred agents and methotrexate is not recommended.
肝脏是结节病最常累及的肺外部位之一。肝结节病的表现范围广泛,从散在的、无症状的非干酪样肉芽肿且肝酶正常(这在已知肺部结节病患者中非常常见)到门静脉高压和肝硬化(相对不常见)。诊断基于临床、实验室和组织学表现的综合判断。作者对于无局灶性病变的疑似肝结节病患者的管理方案包括经颈静脉肝活检并测量门静脉压力,以确诊、排除并存的肝脏疾病,并识别出有纤维化或门静脉高压的特定患者,考虑给予免疫抑制治疗。类固醇和硫唑嘌呤是首选药物,不推荐使用甲氨蝶呤。